4541.T
Price:
$35
Market Cap:
$2.47B
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, imports, and distributes various pharmaceutical products. The company operates through two segments, Sagent Group and Nichi-Iko Group. It primarily focuses on the production of generic drugs. The company offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products. It also provides treatments for circulatory, digestive, respiratory, central and peripheral nervous systems, and others. In addition, the company engages in the packaging design business. Further, it exports its product...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-12-19
Stock Exchange
JPX
Ticker
4541.T
According to Nichi-Iko Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -100.00% compared to the average of -0.42 of the last 4 quarters.
The mean historical PE Ratio of Nichi-Iko Pharmaceutical Co., Ltd. over the last ten years is 11.66. The current -0.00 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), 4541.T's PE Ratio was at its highest in in the September 2016 quarter at 206.70. The PE Ratio was at its lowest in in the March 2019 quarter at -865.43.
Average
11.66
Median
17.26
Minimum
-35.96
Maximum
39.20
Discovering the peaks and valleys of Nichi-Iko Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 9.11%
Maximum Annual PE Ratio = 39.20
Minimum Annual Increase = -261.49%
Minimum Annual PE Ratio = -35.96
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | 0.21 | -115.20% |
| 2022 | -1.36 | -96.21% |
| 2021 | -35.96 | -261.49% |
| 2020 | 22.27 | 9.11% |
| 2019 | 0.24 | -98.90% |
| 2018 | 21.90 | -31.90% |
| 2017 | 32.16 | 154.99% |
| 2016 | 12.61 | -50.13% |
| 2015 | 25.29 | -35.48% |
| 2014 | 39.20 | 6.82% |
The current PE Ratio of Nichi-Iko Pharmaceutical Co., Ltd. (4541.T) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-12.37
5-year avg
-2.92
10-year avg
11.66
Nichi-Iko Pharmaceutical Co., Ltd.’s PE Ratio is
| Company | PE Ratio | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nichi-Iko Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nichi-Iko Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nichi-Iko Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Nichi-Iko Pharmaceutical Co., Ltd. (4541.T)?
What is the highest PE Ratio for Nichi-Iko Pharmaceutical Co., Ltd. (4541.T)?
What is the 3-year average PE Ratio for Nichi-Iko Pharmaceutical Co., Ltd. (4541.T)?
What is the 5-year average PE Ratio for Nichi-Iko Pharmaceutical Co., Ltd. (4541.T)?
How does the current PE Ratio for Nichi-Iko Pharmaceutical Co., Ltd. (4541.T) compare to its historical average?